Swiss biotech company, Evolva, has secured additional funding from investment firm, Nice & Green to accelerate growth in key markets and leverage manufacturing efficiencies.
April 2021 and the COVID-19 saga continues to rumble on with news of an impending third wave throughout Europe. Despite plans to restrict movement, the rules don’t appear to have affected recruitment as NutraIngredients rounds up March’s movers and shakers.
Swiss biotech company Evolva is launching a natural sugar blocker for food and drink applications. L-arabinose is also a reducing sugar, the company’s head of investor and corporate relations tells FoodNavigator.
Swiss biotech firm Evolva recently released their findings from the Resveratrol Supporting Healthy Aging in Women (RESHAW) clinical study, which examined cognition, cerebrovascular function and cardiometabolic markers in postmenopausal women.
